TREVENA INC

Profile

Company Names

TREVENA INC

Addresses

1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA, PA 19406

Phone Numbers

610-354-8840

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$77,499,997.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-05-03 
$59,999,997.00 
$60,000,000.00 
$3.00 
Equity 
1
2010-07-08 
$17,500,000.00 
$41,000,000.00 
$23,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FARAH 
 
CHAMPSI 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  ZELOS THERAPEUTICS INC   |  AEROVANCE INC   |  TREVENA INC   |  CHIMERIX INC   |  KITE PHARMA, INC.   |  ALLAKOS INC.
ROBERT 
 
GARLAND 
DIRECTOR
CARDIOXYL PHARMACEUTICALS INC   |  3-V BIOSCIENCES, INC.   |  ZYNGENIA, INC.   |  CITIZENS BANKSHARES OF SPRINGHILL, INC.   |  TREVENA INC   |  BOSS CONTROLS, LLC   |  DISA, LLC   |  INTELLISPEX, INC.   |  DISA TECHNOLOGIES, INC.
MAXINE 
 
GOWEN 
EXECUTIVE OFFICER, DIRECTOR
TREVENA INC   |  TAMUROBIO INC.   |  ACLARIS THERAPEUTICS, INC.   |  PANORAMA MEDICINE, INC.
TERENCE 
 
MCGUIRE 
DIRECTOR
TREVENA INC
CHRISTOPHER 
 
MIRABELLI 
DIRECTOR
THERACLONE SCIENCES, INC.   |  TREVENA INC   |  APOFORE CORP   |  SYNOVEX CORP   |  GALLEON PHARMACEUTICALS INC   |  PROTEOSTASIS THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.   |  ARO BIOTHERAPEUTICS CO
LONNIE 
 
MOULDER, JR. 
DIRECTOR
TREVENA INC
ROBERT, JR. 
 
RUFFOLO 
DIRECTOR
TREVENA INC
RALPH 
 
SNYDERMAN 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  PROVENTYS, INC   |  XDX, INC.   |  TREVENA INC   |  CRESCENDO BIOSCIENCE, INC.   |  SENGENIX, INC.   |  CAREDX, INC.   |  VERITAS COLLABORATIVE HOLDINGS, LLC   |  ESSENTIAL HEALTH SOLUTIONS INC.   |  ZEALCARE, INC.
DAVID 
 
SOLOMON 
DIRECTOR
LIGHTSPEED TECHNOLOGIES INC   |  IP COMMERCE INC   |  EDGECONNEX, INC.   |  TREVENA INC   |  PEAKCOLO HOLDINGS, INC.   |  DIGITAL FORTRESS HOLDINGS, INC.   |  FACTION HOLDINGS, INC.   |  MERITAGE OPPORTUNITY FUND, LLC   |  MERITAGE INVESTORS, LLC   |  MERITAGE INVESTORS 2, LLC   |  PHARMACEUTICS INTERNATIONAL, INC.   |  MERITAGE INVESTORS 3, LLC   |  MERITAGE INVESTORS 4, LLC   |  MERITAGE INVESTORS 2018, LLC   |  TF INVESTORS LLC   |  MERITAGE FACTION SPV LLC   |  TFI BONFIRE CO-INVESTMENT SPV, LLC   |  TFI 828 CO-INVESTMENT SPV, LLC   |  SAPIENT INDUSTRIES, INC.   |  HILDRED CAPITAL CO-INVEST-DC, LP   |  HILDRED EQUITY PARTNERS II, LP   |  HILDRED EQUITY ASSOCIATES II, LP   |  HEALTHCARE, INC.   |  HILDRED EQUITY PARTNERS III-A, LP   |  HILDRED EQUITY PARTNERS III, LP   |  HILDRED EQUITY PARTNERS III-B, LP   |  HILDRED CAPITAL CO-INVEST-REBA, LP   |  LEGAL DECODER, INC.   |  HILDRED CAPITAL CO-INVEST-TB, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-05-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-03 
2010-07-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#